10:09 AM EST - Helix BioPharma Corp. : announced the issuance of a patent (U.S. Patent No. 7,872,105 B2) by the United States Patent & Trademark Office for the non-small cell lung cancer-specific antibody component of its L-DOS47 drug candidate. Helix BioPharma Corp.
shares T.HBP are trading even at $3.10.
